NO164904C - Analogifremgangsmaate til fremstilling av terapeutisk aktive griseolsyrederivater. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive griseolsyrederivater.

Info

Publication number
NO164904C
NO164904C NO844291A NO844291A NO164904C NO 164904 C NO164904 C NO 164904C NO 844291 A NO844291 A NO 844291A NO 844291 A NO844291 A NO 844291A NO 164904 C NO164904 C NO 164904C
Authority
NO
Norway
Prior art keywords
acid derivatives
preparation
griseolic acid
therapeutic active
analogy procedure
Prior art date
Application number
NO844291A
Other languages
English (en)
Norwegian (no)
Other versions
NO164904B (no
NO844291L (no
Inventor
Masakatsu Kaneko
Misako Kimura
Yoshinobu Murofushi
Mitsuo Yamazaki
Nobuyoshi Iwata
Fumio Nakagawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO844291L publication Critical patent/NO844291L/no
Publication of NO164904B publication Critical patent/NO164904B/no
Publication of NO164904C publication Critical patent/NO164904C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Insulating Materials (AREA)
  • Fats And Perfumes (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
NO844291A 1983-10-28 1984-10-29 Analogifremgangsmaate til fremstilling av terapeutisk aktive griseolsyrederivater. NO164904C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58202362A JPS6094992A (ja) 1983-10-28 1983-10-28 グリゼオ−ル酸誘導体

Publications (3)

Publication Number Publication Date
NO844291L NO844291L (no) 1985-04-29
NO164904B NO164904B (no) 1990-08-20
NO164904C true NO164904C (no) 1990-11-28

Family

ID=16456245

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844291A NO164904C (no) 1983-10-28 1984-10-29 Analogifremgangsmaate til fremstilling av terapeutisk aktive griseolsyrederivater.

Country Status (12)

Country Link
US (1) US4634706A (ko)
EP (1) EP0143557B1 (ko)
JP (1) JPS6094992A (ko)
KR (1) KR930000165B1 (ko)
AT (1) ATE39357T1 (ko)
CA (1) CA1267408A (ko)
DE (1) DE3475714D1 (ko)
DK (1) DK166323C (ko)
ES (4) ES8604737A1 (ko)
FI (1) FI81357C (ko)
NO (1) NO164904C (ko)
SU (4) SU1600632A3 (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783532A (en) * 1983-10-28 1988-11-08 Sankyo Company Limited Process for preparing griseolic acid derivatives
IT1196261B (it) * 1984-09-20 1988-11-16 Pierrel Spa Derivati nucleosidici e purinici 8-sostituiti
EP0319050B1 (en) 1985-04-19 1995-04-12 Sankyo Company Limited Griseolic acid derivatives, their preparation and their use
DK167878B1 (da) * 1985-04-19 1993-12-27 Sankyo Co Griseolsyrederivater
JPH0631307B2 (ja) * 1985-04-27 1994-04-27 三共株式会社 グリゼオ−ル酸誘導体の製法
US5214048A (en) * 1987-05-19 1993-05-25 Nippon Kayaku Kabushiki Kaisha Oxetanocins
JPH0774229B2 (ja) * 1987-12-02 1995-08-09 三共株式会社 グリゼオール酸モノエステル誘導体
US5091431A (en) * 1988-02-08 1992-02-25 Schering Corporation Phosphodiesterase inhibitors
JPH0689020B2 (ja) * 1988-06-30 1994-11-09 三共株式会社 グリゼオール酸のモノエステル誘導体
US4971972A (en) * 1989-03-23 1990-11-20 Schering Corporation Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion
JP3645580B2 (ja) * 1993-10-22 2005-05-11 株式会社フジモト・ブラザーズ グルコースエステル誘導体を含有する脳代謝改善剤
US6291516B1 (en) * 1999-01-13 2001-09-18 Curis, Inc. Regulators of the hedgehog pathway, compositions and uses related thereto
EP1312363A1 (en) * 2001-09-28 2003-05-21 Pfizer Products Inc. Methods of treatment and kits comprising a growth hormone secretagogue
US7342884B2 (en) * 2002-03-13 2008-03-11 Harmonic, Inc. Method and apparatus for one directional communications in bidirectional communications channel
WO2011081915A2 (en) * 2009-12-15 2011-07-07 Cebix Inc. Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
US20230294012A1 (en) * 2021-02-19 2023-09-21 Anhui Jinhe Industrial Co., Ltd. Production apparatus and production method of sucrose-6-ester

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4138562A (en) * 1977-02-09 1979-02-06 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
JPS5668695A (en) * 1979-11-10 1981-06-09 Sankyo Co Ltd Enzyme inhibitor griseolic acid and its preparation
DE3028273A1 (de) * 1980-07-25 1982-02-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Durch purinbasen substituierte 1.4;3.6-dianhydro-hexit-nitrate
JPS60246396A (ja) * 1984-05-22 1985-12-06 Sankyo Co Ltd 酵素阻害物質ジヒドロデスオキシグリゼオ−ル酸及びその塩類

Also Published As

Publication number Publication date
ES537154A0 (es) 1985-12-01
JPH0432837B2 (ko) 1992-06-01
CA1267408A (en) 1990-04-03
EP0143557B1 (en) 1988-12-21
ES8701193A1 (es) 1986-11-16
FI81357B (fi) 1990-06-29
KR930000165B1 (ko) 1993-01-11
KR850003415A (ko) 1985-06-17
SU1468421A3 (ru) 1989-03-23
EP0143557A2 (en) 1985-06-05
ATE39357T1 (de) 1989-01-15
SU1600632A3 (ru) 1990-10-15
ES547291A0 (es) 1986-11-16
ES547292A0 (es) 1986-02-16
DK513384A (da) 1985-04-29
ES8604981A1 (es) 1986-02-16
FI81357C (fi) 1990-10-10
DE3475714D1 (en) 1989-01-26
SU1604158A3 (ru) 1990-10-30
DK513384D0 (da) 1984-10-26
DK166323C (da) 1993-08-30
DK166323B (da) 1993-04-05
ES8604737A1 (es) 1985-12-01
ES547347A0 (es) 1986-10-16
NO164904B (no) 1990-08-20
JPS6094992A (ja) 1985-05-28
FI844225L (fi) 1985-04-29
US4634706A (en) 1987-01-06
ES8700673A1 (es) 1986-10-16
SU1468422A3 (ru) 1989-03-23
EP0143557A3 (en) 1985-07-03
FI844225A0 (fi) 1984-10-26
NO844291L (no) 1985-04-29

Similar Documents

Publication Publication Date Title
NO164904C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive griseolsyrederivater.
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
NO172344C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter
MD707C2 (ro) Derivaţi ai sulfonilureei, procedeu de obţinere a lor, produse intermediare pentru ei, substanţă pe baza lor cu acţiune erbicidă şi de reprimare a creşterii plantelor, procedeu de combatere a buruienilor
ATE81004T1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
ES438931A1 (es) Procedimiento para la preparacion de nuevos derivados de amino-3 hidroxi-2 fenoxi-1 propano.
IT1224405B (it) Composti attivi sul sistema cardiovascolare
PH23818A (en) Enhancement of activity of alpha-adrenoceptor antagonists
DE3570249D1 (en) Enzyme-inhibitory griseolic acid derivatives, and their use
MY110092A (en) Butyric acid derivatives
FI932654A0 (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
ATE50248T1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease
IL106107A0 (en) Imidazolyl-substituted cyclohexane derivatives,their preparation and pharmaceutical compositions containing them
PT1059845E (pt) Composicao fungicida compreendendo uma benzoilfenilureia
ES469020A1 (es) Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos
IT8719093A0 (it) Derivati di esteri dell'acido immidazol-1-il-carbossilico, procedimenti per la loro preparazione e composizioni fungicide che contengono il derivato come componente attivo.
GB1470747A (en) Pyridazine derivative
DE3782235D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
IT1224404B (it) Composti attivi sul sistema cardiovascolare
GEP19980890B (en) Derivatives of N1-(1,2-Cis-halogeno¬-cyclopropyl) Substituted Pyridonecarbonic Acid
JPS5432482A (en) 3,4-dihydrocarbostyril derivatives and bactericides containing the same as active agnet for agricultural and horticultural uses